- Previous Close
0.00 - Open
37.71 - Bid 44.70 x 36100
- Ask 47.65 x 21500
- Day's Range
37.71 - 37.71 - 52 Week Range
28.75 - 48.05 - Volume
235 - Avg. Volume
869 - Market Cap (intraday)
44.1B - Beta (5Y Monthly) --
- PE Ratio (TTM)
8.40 - EPS (TTM)
5.44 - Earnings Date Nov 14, 2024
- Forward Dividend & Yield 0.83 (1.82%)
- Ex-Dividend Date Nov 29, 2024
- 1y Target Est
--
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health; healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, clinical services and B2B contract services; medical devices and technology including devices, medical equipment and consumables, diagnostics, and healthcare IT. In services and software, it focuses on IT services including cloud and IT infrastructure managed services providers, software vendor integration and support services or application, and software development or DevOps; tech-enabled outsourcing services including testing, inspection and certification, human capital management or business information, and data & analytics; mature software including horizontal software, vertical software, office of the CFO, supply chain, ERP, human capital and life sciences. In the industrial sector, it focuses on automotive, chemicals, safety and security, construction, building products and materials, energy, electronics and electrical components, flow control and filtration, mobility, packaging, industrial CMO, B2B distribution, safety & security, industrial services including industrial software, oil, gas, and power. Through 3i BIFM Limited and 3i Infrastructure plc the firm makes infrastructure investments where it focuses principally on the utilities including energy transmission and storage, electricity and gas distribution, water, power generation, and communication network; transportation including airports, ports, ferries, toll roads, and rail; and social infrastructure sector including primary and secondary PFI, public private partnerships, healthcare, education, and government accommodation. In infrastructure it invests primarily in utilities, transportation and social infrastructure in the United Kingdom, France, Italy, Germany, Europe, and Ireland. The firm prefers to invest in companies across Europe, France, United States, South America, and Asia. It seeks to make new investments in Northern Europe and North America. The firm typically invests in companies with enterprise value between 100 million ($108.48 million) and 500 million ($543.42 million). It seeks to take either majority or minority stakes. It seeks to take a board seat in its portfolio companies with regards to infrastructure investments. The firm invests through a combination of third-party and proprietary capital. It invests through its personal capital. 3i Group plc was founded in 1945 and is based in London, United Kingdom with additional offices across North America and Europe.
www.3i.com249
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: TGOPF
View MorePerformance Overview: TGOPF
Trailing total returns as of 1/8/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TGOPF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TGOPF
View MoreValuation Measures
Market Cap
44.14B
Enterprise Value
--
Trailing P/E
8.39
Forward P/E
8.18
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.09
Price/Book (mrq)
1.61
Enterprise Value/Revenue
8.36
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
5.44
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--